Page last updated: 2024-09-03

bradykinin, leu(8)-des-arg(9)- and glucose, (beta-d)-isomer

bradykinin, leu(8)-des-arg(9)- has been researched along with glucose, (beta-d)-isomer in 1 studies

Compound Research Comparison

Studies
(bradykinin, leu(8)-des-arg(9)-)
Trials
(bradykinin, leu(8)-des-arg(9)-)
Recent Studies (post-2010)
(bradykinin, leu(8)-des-arg(9)-)
Studies
(glucose, (beta-d)-isomer)
Trials
(glucose, (beta-d)-isomer)
Recent Studies (post-2010) (glucose, (beta-d)-isomer)
1020721,95688310,747

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Rashed, S; Brain, SD; Cao, T; Gerard, N; Hoult, JR; Pintér, E1

Other Studies

1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and glucose, (beta-d)-isomer

ArticleYear
Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice.
    Journal of immunology (Baltimore, Md. : 1950), 2000, May-15, Volume: 164, Issue:10

    Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Carrageenan; Cell Movement; Drug Combinations; Female; Injections, Intradermal; Injections, Intravenous; Interleukin-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Neutrophils; Receptors, Neurokinin-1; Skin; Substance P; Zymosan

2000